Back to Authors

Lopes, Michelle Ugolini

A5102698461 | I168537998

Mayo Clinic

Eli Lilly (United States)

Citations 2

Efficacy of Mirikizumab in Comparison to Ustekinumab in Patients With Moderate-to-Severe Crohn’s Disease: Results From the Phase 3 VIVID-1 Study

Zeitschrift für Gastroenterologie | November 27, 2025 | Volume: 62 | Issue: 05 | Pages: e481-e482

10.1055/s-0044-1786891

P115 Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate-to-severe Crohn’s disease: results from phase 3 VIVID 1 study

Poster Presentations | July 1, 2024 | Volume: No volume available | Issue: No issue available | Pages: A120.1-A120

10.1136/gutjnl-2024-bsg.197